IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology. (Q49477908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

title

IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Kostas Stylianou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

30

Christos Iatrou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

29

Eugene Daphnis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

Marios Papasotiriou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Dimitrios Xydakis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Theodora Oikonomaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Smaragdi Marinaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Synodi Zerbala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Pantelitsa Kalliakmani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Aimilios Andrikos

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Antonia Papadaki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Olga Balafa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Spyridon Golfinopoulos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Georgios Visvardis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Georgios Moustakas

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Evangelos Papachristou

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Theodora Kouloukourgiotou

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Eleni Kapsia

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Angeliki Panagiotou

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Constantinos Koulousios

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Christos Kavlakoudis

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Maria Georgopoulou

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Stylianos Panagoutsos

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Demetrios V Vlahakos

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Theophanis Apostolou

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Ioannis Stefanidis

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Kostas Siamopoulos

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Ioannis Tzanakis

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Apostolos Papadogiannakis

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

John N Boletis

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Aikaterini Papagianni

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Dimitrios S Goumenos

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

publication date

31 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association)

15 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

38-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.

15 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

The MEST score provides earlier risk prediction in lgA nephropathy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Current therapy for IgA nephropathy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Steroids and azathioprine in the treatment of IgA nephropathy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Long-term study of mycophenolate mofetil treatment in IgA nephropathy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Histology and immunohistology of IgA nephropathy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Factors predicting progression of IgA nephropathies.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

The commonest glomerulonephritis in the world: IgA nephropathy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Immunosuppressive therapy in patients with IgA nephropathy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Clinical implication of crescentic lesions in immunoglobulin A nephropathy

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Meta-analysis of mycophenolate mofetil in IgA nephropathy

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5798157

The clinical course of mesangial IgA associated nephropathy in adults

14 August 2018

1 reference

12 December 2020

Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy

1 reference

12 December 2020

The "point of no return" and the rate of progression in the natural history of IgA nephritis

1 reference

12 December 2020

1 reference

12 December 2020

Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study

1 reference

12 December 2020

Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy

1 reference

12 December 2020

1 reference

12 December 2020

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine

1 reference

12 December 2020

Treatment of IgA nephropathy based on the severity of clinical and histological features

1 reference

12 December 2020

Identifiers

DOI

10.1093/CKJ/SFX076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29423199%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference